Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblastsLisa Nocquet, Frédérique Souazé|Scientific Reports|2024Cited by 15
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cellsLisa Nocquet, Frédérique Souazé|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1